Suppr超能文献

草药SGR配方通过抑制小鼠脂肪生成和增强脂肪酸氧化来预防急性乙醇诱导的肝脂肪变性。

Herbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in Mice.

作者信息

Qiu Ping, Li Xiang, Kong De-Song, Li Huan-Zhou, Niu Cong-Cong, Pan Su-Hua

机构信息

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China ; National First-Class Key Discipline for Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China ; Zhejiang Chinese Medical University, Hangzhou 310053, China.

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China ; National First-Class Key Discipline for Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.

出版信息

Evid Based Complement Alternat Med. 2015;2015:613584. doi: 10.1155/2015/613584. Epub 2015 May 25.

Abstract

Our previous study indicated that herbal SGR formula partially attenuates ethanol-induced fatty liver, but the underlying mechanisms remain unclear. In the present study, mice were pretreated with SGR (100 and 200 mg/kg/d bw) for 30 d before being exposed to ethanol (4.8 g/kg bw). The biochemical indices and histopathological changes were examined to evaluate the protective effects and to explore potential mechanisms by investigating the adiponectin, tumor necrosis factor-α (TNF-α), peroxisome proliferators-activated receptor-α (PPAR-α), sterol regulatory element binding protein-1c (SREBP-1c), adenosine monophosphate-activated protein kinase (AMPK), and so forth. Results showed that SGR pretreatment markedly inhibited acute ethanol-induced liver steatosis, significantly reduced serum and hepatic triglyceride (TG) level, and improved classic histopathological changes. SGR suppressed the protein expression of hepatic SREBP-1c and TNF-α and increased adiponectin, PPAR-α, and AMPK phosphorylation in the liver. Meanwhile, acute toxicity tests showed that no death or toxic side effects within 14 days were observed upon oral administration of the extracts at a dose of 16 g/kg body wt. These results demonstrate that SGR could protect against acute alcohol-induced liver steatosis without any toxic side effects. Therefore, our studies provide novel molecular insights into the hepatoprotective effect of SGR formula, which may be exploited as a therapeutic agent for ethanol-induced hepatosteatosis.

摘要

我们之前的研究表明,草药SGR配方可部分减轻乙醇诱导的脂肪肝,但潜在机制仍不清楚。在本研究中,小鼠在暴露于乙醇(4.8 g/kg体重)之前,先用SGR(100和200 mg/kg/d体重)预处理30天。通过检测脂联素、肿瘤坏死因子-α(TNF-α)、过氧化物酶体增殖物激活受体-α(PPAR-α)、固醇调节元件结合蛋白-1c(SREBP-1c)、腺苷单磷酸激活蛋白激酶(AMPK)等指标,检查生化指标和组织病理学变化,以评估保护作用并探索潜在机制。结果表明,SGR预处理显著抑制急性乙醇诱导的肝脂肪变性,显著降低血清和肝脏甘油三酯(TG)水平,并改善经典组织病理学变化。SGR抑制肝脏SREBP-1c和TNF-α的蛋白表达,并增加肝脏中脂联素、PPAR-α和AMPK的磷酸化。同时,急性毒性试验表明,口服剂量为16 g/kg体重的提取物后14天内未观察到死亡或毒副作用。这些结果表明,SGR可以预防急性酒精诱导的肝脂肪变性,且无任何毒副作用。因此,我们的研究为SGR配方的肝保护作用提供了新的分子见解,其可能被开发为乙醇诱导的肝脂肪变性的治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d12b/4458561/fc54a2b38456/ECAM2015-613584.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验